Financial statements Bioxus Lab

Balance sheet of Bioxus Lab

Company age:
Age:
7 y. 11 m. 6 d.
Share capital:
Share capital:
50 000 PLN
Company suspended its operations from 2025-01-17
Profit and loss statement Balance Profitability

Balance sheet data of BIOXUS LAB

Year
2018
2019
2020
2021
2022
2023
Total assets 109 995,88 223 359,82 154 288,78 149 804,81 130 639,72 137 890,87
A. Fixed assets 1 000,00 1 000,00 1 000,00 1 000,00 1 000,00 1 000,00
B. Current assets 108 995,88 222 359,82 153 288,78 148 804,81 129 639,72 136 890,87
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 109 995,88 223 359,82 154 288,78 149 804,81 130 639,72 137 890,87
A. Equity 109 995,88 111 194,89 103 378,95 97 120,67 78 275,02 69 421,60
B. Liabilities and provisions for liabilities 0,00 112 164,93 50 909,83 52 684,14 52 364,70 68 469,27
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 0,00 112 164,93 50 909,83 52 684,14 52 364,70 51 273,02
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.